Concordance of blind versus TMD-based dosing adjustments of infliximab therapy in spondyloarthritis and rheumatoid arthritis: the COPINFLIX study

首页> 外文期刊>Fundamental & clinical pharmacology. >Concordance of blind versus TMD-based dosing adjustments of infliximab therapy in spondyloarthritis and rheumatoid arthritis: the COPINFLIX study

【24h】

Concordance of blind versus TMD-based dosing adjustments of infliximab therapy in spondyloarthritis and rheumatoid arthritis: the COPINFLIX study

机译：盲人与TMD的盲素治疗在脊椎炎和类风湿性关节炎中的TMD系染量调整的一致性：Copinflix研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Fundamental & clinical pharmacology.》 |2019年第s1期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Concordance of blind versus TMD-based dosing adjustments of infliximab therapy in spondyloarthritis and rheumatoid arthritis: the COPINFLIX study [J] . Fundamental & clinical pharmacology. . 2019,第S1期

机译：盲人与TMD的盲素治疗在脊椎炎和类风湿性关节炎中的TMD系染量调整的一致性：Copinflix研究
2. Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results [J] . Yuji Nozaki, Yasuaki Nagare, Chisato Ashida, Biologics: Targets and Therapy . 2018,第2期

机译：英夫利昔单抗剂量调整可改善类风湿关节炎患者的临床和放射学结果：REVIVE研究结果
3. Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: A double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study) [J] . NamJ.L., VilleneuveE., HensorE.M.A., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第1期

机译：比较英夫利昔单抗和大剂量静脉内类固醇的缓解诱导，然后进行靶向治疗：一项针对新发，未经治疗的类风湿关节炎的双盲，随机对照试验（IDEA研究）
4. COMPARING STATISTICS WITH MACHINE LEARNING MODELS TO PREDICT DOSE INCREASE OF INFLIXIMAB FOR RHEUMATOID ARTHRITIS PATIENTS [C] . Stijn Van Looy, Bert Vander Cruyssen, Bart Wyns, IASTED International Conference on Artificial Intelligence and Soft Computing . 2005

机译：将统计数据与机器学习模型进行比较，以预测类风湿性关节炎患者英夫利昔单抗的剂量增加
5. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
6. Extended report: A randomised double-blind phase III study comparing SB2 an infliximab biosimilar to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy [O] . Jung-Yoon Choe, Nenad Prodanovic, Jaroslaw Niebrzydowski, -1

机译：扩展报告：在甲氨蝶呤治疗中重度类风湿关节炎患者中一项英夫利昔单抗生物仿制药SB2与英夫利昔单抗参考产品Remicade进行的一项随机双盲III期临床研究
7. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy [O] . K Pavelka, K Jarosova, D Suchy, 2009

机译：增加流链关节炎患者的英夫昔单抗剂量：随机，双盲研究未能确认其功效

Concordance of blind versus TMD-based dosing adjustments of infliximab therapy in spondyloarthritis and rheumatoid arthritis: the COPINFLIX study

著录项

相似文献

相关主题

期刊订阅